All Health Articles
Nedosiran for Primary Hyperoxaluria Type 1 - An Overview
Nedosiran is an RNA-targeted therapy to reduce oxalate production by inhibiting hepatic lactate dehydrogenase, thus treating primary hyperoxaluria Type 1.
7 min readFebruary 29, 2024
